BTZ-043

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBTZ-043
Drug Alias NameBTZ-043
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors
TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase
Therapy Area/IndicationsLung DiseasesRespirovirus InfectionsTuberculosis, Pulmonary +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsSouth AfricaGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHans Knöll Institute
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical CenterLeibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute
Inactive CompaniesHans Knöll Institute (Hki)
Active IndicationsLung DiseasesRespirovirus InfectionsTuberculosis, Pulmonary +[5] 
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A